Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjalling Bosse

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Nature Medicine|April 24, 2019
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneityOded Kopper, Chris J de Witte, Kadi Lõhmussaar, et al.
The Lancet. Oncology|December 25, 2025
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trialAnne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I E van Poelgeest, Marij J P Welters, Renee Vermeij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian CarcinomaPauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2020
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancerAnne Sophie V M van den Heerik, Nanda Horeweg, Remi A Nout, et al.
Gynecologic Oncology|May 6, 2026
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiativeMarcel Grube, Bianca Ribeiro de Souza, Andrea Neilson, et al.
Annals of Diagnostic Pathology|November 26, 2024
Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobankHein S Zelisse, Mignon D J M van Gent, Constantijne H Mom, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Nature Medicine|April 24, 2019
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneityOded Kopper, Chris J de Witte, Kadi Lõhmussaar, et al.
The Lancet. Oncology|December 25, 2025
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trialAnne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I E van Poelgeest, Marij J P Welters, Renee Vermeij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian CarcinomaPauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2020
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancerAnne Sophie V M van den Heerik, Nanda Horeweg, Remi A Nout, et al.
Gynecologic Oncology|May 6, 2026
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiativeMarcel Grube, Bianca Ribeiro de Souza, Andrea Neilson, et al.
Annals of Diagnostic Pathology|November 26, 2024
Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobankHein S Zelisse, Mignon D J M van Gent, Constantijne H Mom, et al.
Pageof 17